List of works - Moshe C Ornstein

A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma.

scientific article published on 23 January 2017

A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy

scientific article published on 16 May 2019

Clinical Effect of Dose Escalation After Disease Progression in Patients With Metastatic Renal Cell Carcinoma.

scientific article

Combination strategies in myelodysplastic syndromes.

scientific article published on 06 January 2012

Dying revisited: understanding the process, six years later

scientific article

Emerging immunotherapy in advanced renal cell carcinoma

scientific article published on 7 September 2017

Imaging the immune response to monitor tumor immunotherapy.

scientific article published on October 2009

Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy

scientific article published on 7 January 2015

Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date

scientific article published on 23 June 2020

More is better: combination therapies for myelodysplastic syndromes.

scientific article published on 11 November 2014

Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)

scientific article published on 20 April 2022

Screening for functional kinases in metastatic prostate cancer: a glimmer of hope for kinase inhibition.

scientific article

State of the evidence: mechanical ventilation with PEEP in patients with cardiogenic shock

scientific article

Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)

scientific article published on 04 June 2019

The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition

scientific article published on 11 May 2017

The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinoma.

scientific article published on 4 May 2016

List of works by Moshe C Ornstein

A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma.

A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy

Clinical Effect of Dose Escalation After Disease Progression in Patients With Metastatic Renal Cell Carcinoma.

Combination strategies in myelodysplastic syndromes.

Dying revisited: understanding the process, six years later

Emerging immunotherapy in advanced renal cell carcinoma

Imaging the immune response to monitor tumor immunotherapy.

Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy

Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date

More is better: combination therapies for myelodysplastic syndromes.

Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)

Screening for functional kinases in metastatic prostate cancer: a glimmer of hope for kinase inhibition.

State of the evidence: mechanical ventilation with PEEP in patients with cardiogenic shock

Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)

The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition

The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinoma.